Mohamadamin Tarighat-Payma

Dr. Mohamadamin Tarighat-Payma

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGMohammadreza Ghaffarzadeh-Esfahani
Mohammadreza Ghaffarzadeh-Esfahani
MGMahdi Ghaffarzadeh-Esfahani
Mahdi Ghaffarzadeh-Esfahani
ASAryan Salahi-Niri
Aryan Salahi-Niri
HTHossein Toreyhi
Hossein Toreyhi
ZAZahra Atf
Zahra Atf
SSSeyed Amir Ahmad Safavi-Naini
Seyed Amir Ahmad Safavi-Naini
This study compared the performance of classical feature-based machine learning models (CMLs) and large language models (LLMs) in predicting COVID-19 mortality using high-dimensional tabular data from 9,134 patients across four hospitals. Seven CML models, including XGBoost and random forest (RF), were evaluated alongside eight LLMs, such as GPT-4 and Mistral-7b, which performed zero-shot classification on text-converted structured data. Additionally, Mistral-7b was fine-tuned using the QLoRA approach. XGBoost and RF demonstrated superior performance among CMLs, achieving F1 scores of 0.87 and 0.83 for internal and external validation, respectively. GPT-4 led the LLM category with an F1 score of 0.43, while fine-tuning Mistral-7b significantly improved its recall from 1% to 79%, yielding a stable F1 score of 0.74 during external validation. Although LLMs showed moderate performance in zero-shot classification, fine-tuning substantially enhanced their effectiveness, potentially bridging the gap with CML models. However, CMLs still outperformed LLMs in handling high-dimensional tabular data tasks. This study highlights the potential of both CMLs and fine-tuned LLMs in medical predictive modeling, while emphasizing the current superiority of CMLs for structured data analysis.

16 February 2026 in Journal of Translational Autoimmunity
Verified
Journal Article
Open access
MTMohamadamin Tarighat-Payma
Mohamadamin Tarighat-Payma
LMLadan Mehran
Ladan Mehran
SMSafdar Masoumi
Safdar Masoumi
MTMaryam Tohidi
Maryam Tohidi
AAAtieh Amouzegar
Atieh Amouzegar
EPElizabeth N. Pearce
Elizabeth N. Pearce
Thyroid peroxidase antibody (TPOAb) is considered a highly sensitive marker of autoimmune thyroid diseases (AITD). Limited longitudinal data exist regarding its long-term natural history in the general population. This study aimed to assess risk factors for TPOAb positivity and its 18-year prevalence, incidence, trajectories, and projected prevalence for the year 2030 in a population-based cohort. A total of 5,438 adults were recruited at first visit (1999-2002) and followed across four subsequent visits up to 2018 in the iodine-sufficient population-based Tehran Thyroid Study (TTS). The age- and sex-standardized prevalence of TPOAb positivity was calculated, and the projected prevalence in 2030 was estimated using Poisson Generalized Linear Mixed Model (Poisson GLMM). Longitudinal trajectories of TPOAb were identified using latent class growth mixture model (LCGMM). Cox proportional hazards models were used to examine associations between potential risk factors and TPOAb positivity. The prevalence increased progressively from 11.7% at the first visit (1999-2002) to 16.3% at the fifth visit (2015-2018), and is projected to reach 21.04% in 2030. Four distinct TPOAb trajectories were identified: Low-stable (81.4%), Low-increasing (2.9%), High-decreasing (2.4%), and High-stable (13.3%). The overall incidence rate of TPOAb positivity was 5.6 per 1,000 person-years, higher among women and individuals aged <40 years. In multivariable analysis, female sex (Hazard Ratio (HR) = 1.61; 95% CI: 1.15-2.27) and elevated TSH ≥5 mU/L (HR = 2.69; 95% CI: 1.57-4.63) were significant positive predictors of TPOAb positivity, while age between 40 and 60 years was inversely associated with incident TPOAb positivity (HR = 0.71; 95% CI: 0.55-0.90). This is the first and longest study worldwide that demonstrated a persistent rise in TPOAb positivity across five repeated measurements in an iodine-sufficient population, driven by female sex, age <40, and TSH ≥5 mU/L, which is projected to reach 21.04% in 2030. Trajectory patterns of TPOAb showed that the majority of participants had consistently low-stable levels of TPOAb.

29 April 2026 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
LMLadan Mehran
Ladan Mehran
MTMohamadamin Tarighat-Payma
Mohamadamin Tarighat-Payma
SMSafdar Masoumi
Safdar Masoumi
AAAlireza Amirabadizadeh
Alireza Amirabadizadeh
FAFereidoun Azizi
Fereidoun Azizi
AAAtieh Amouzegar
Atieh Amouzegar
Context: Thyroid dysfunction and type 2 diabetes mellitus (T2DM) are common endocrine disorders with substantial public health implications. Increasing evidence suggests that alterations in thyroid function may influence glycemic regulation and the risk of T2DM. However, long-term population-based evidence on this relationship remains limited. Therefore, this study aimed to summarize the association between thyroid function and T2DM using findings from the Tehran Thyroid Study (TTS), a large community-based cohort with nearly 2 decades of follow-up. Evidence Acquisition: A literature search was performed in PubMed, Scopus, Web of Science, and the library of the Research Institute for Endocrine Sciences to identify articles within the TTS framework. The retrieved articles were categorized according to their primary predictors and outcomes, including T2DM, thyroid function, thyroid hormone sensitivity, and insulin resistance. Results: Over 18 years, a longitudinal analysis of 1938 adults showed that each unit increase in log-transformed thyroid-stimulating hormone (TSH) was associated with a 25% lower risk of developing T2DM (HR, 0.75; 95% CI, 0.64 - 0.90), whereas higher free thyroxine (FT4) levels were associated with a slightly increased risk of T2DM. Cross-sectional data indicated that overt and subclinical hyperthyroidism significantly increased the odds of hyperglycemia, with the highest prevalence (31.3%) observed in subclinical hyperthyroidism. In studies of thyroid hormone sensitivity, a 1-SD increase in the thyroid feedback quantile-based index (TFQI) was associated with higher odds of T2DM, whereas higher central sensitivity indices were associated with lower odds of prediabetes. Lower FT4 levels were independently associated with higher insulin resistance in euthyroid men but not in women. Patients with diabetes had a higher prevalence of subclinical hyperthyroidism but a lower incidence of thyroid dysfunction compared with controls. Conclusions: Trends toward lower TSH or relatively higher FT4 levels are associated with an increased incidence of T2DM. Both overt and subclinical hyperthyroidism are associated with hyperglycemia. Current evidence supports targeted metabolic monitoring in individuals with thyroid hormone excess or altered thyroid sensitivity indices but does not justify routine thyroid-directed therapy solely to prevent T2DM.

28 February 2026 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
AAAtieh Amouzegar
Atieh Amouzegar
MTMohamadamin Tarighat-Payma
Mohamadamin Tarighat-Payma
SMSafdar Masoumi
Safdar Masoumi
AAAlireza Amirabadizadeh
Alireza Amirabadizadeh
HAHengameh Abdi
Hengameh Abdi
LMLadan Mehran
Ladan Mehran
Context: Thyroid dysfunction and metabolic syndrome (MetS) share similar pathophysiological features, suggesting a bidirectional relationship between these two prevalent endocrinological disorders. This review summarizes findings from 18 years of follow-up in the Tehran Thyroid Study (TTS), a large community-based prospective cohort, focusing on the association between thyroid function and MetS. Evidence Acquisition: We systematically reviewed TTS publications (until 2025) on thyroid function and MetS. Exposures included thyroid-stimulating hormone (TSH), free thyroxine (FT4), thyroid peroxidase antibody (TPOAb), and thyroid feedback indices [Thyroid Feedback Quantile-Based Index (TFQI), Thyrotroph T4 Resistance Index (TT4RI), and TSH Index (TSHI)]. Outcomes were MetS and its components. Study designs ranged from cross-sectional and prospective cohort to joint longitudinal/time-to-event models. Results: Cross-sectional TTS analyses showed an inverse association between FT4 (but not TSH) and the prevalence of MetS. Among 3,755 euthyroid adults, a 1-unit increase in FT4 was associated with lower odds of MetS (OR 0.96, 95% CI: 0.92 - 0.99). Across thyroid functional states, overt hypothyroidism had the highest MetS prevalence (41.6%); in men, overt hypothyroidism was associated with higher odds of MetS versus euthyroidism (OR 2.9, 95% CI: 1.04 - 8.40). Prospective TTS analyses supported a modest thyroid-to-MetS direction. In a 10-year cohort of 2,393 participants without MetS at baseline, declining FT4 over follow-up predicted incident MetS in non-obese adults (OR 0.57, 95% CI: 0.34 - 0.96) and was associated with lower odds of incident abdominal obesity and hypertriglyceridemia. In joint longitudinal-time-to-event models (n = 1,436; median 9-year follow-up), higher time-varying TSH was associated with higher MetS risk (HR 1.17, 95% CI: 1.01 - 1.28), while higher FT4 predicted lower MetS risk (HR 0.54, 95% CI: 0.29 - 0.97). In the reverse direction, baseline MetS did not independently predict incident thyroid dysfunction over 9 years (n = 4,905; adjusted HR, 0.95; 95% CI: 0.77 - 1.18). Thyroid hormone sensitivity indices were not associated with MetS overall, although higher TFQI was associated with hypertension (OR 1.14, 95% CI: 1.05 - 1.23). Conclusions: Eighteen years of follow-up in TTS suggest a modest, mostly one-way thyroid-MetS association. Higher (or high-normal) TSH and lower FT4 modestly increase MetS risk, whereas baseline MetS did not significantly increase the risk of later thyroid dysfunction.

6 February 2026 in Thyroid®
Verified
Journal Article
Closed access
LMLadan Mehran
Ladan Mehran
AAAtieh Amouzegar
Atieh Amouzegar
SMSafdar Masoumi
Safdar Masoumi
MHMehdi Hedayati
Mehdi Hedayati
PMParvin Mirmiran
Parvin Mirmiran
FAFereidoun Azizi
Fereidoun Azizi
Background: Iodine deficiency disorders (IDDs) remain a public health concern, especially in pregnancy, despite universal salt iodization (USI) programs. Iran has sustained iodine sufficiency since the 1990s through national USI, but recent evidence suggests recurrent iodine insufficiency among pregnant women. This study reports findings from the sixth National Monitoring Survey (2022–2023) to reassess iodine status in schoolchildren and pregnant women in Iran. Methods: This cross-sectional survey included 11,221 schoolchildren aged 8–10 years and 2929 pregnant women from all 31 provinces. Multistage cluster sampling ensured national representativeness for children. At the same time, pregnant women were recruited from health centers by equal provincial quotas (60 per province, not population-weighted), and their individual intake of iodide along with folic acid supplements was documented. Urinary iodine concentration (UIC) was measured using the Sandell–Kolthoff method, and salt iodine content was assessed by iodometric titration at production and household levels. Data were analyzed with descriptive and nonparametric statistical methods. Results: The median UIC in schoolchildren was 133 µg/L (interquartile range [IQR]: 88–183), within the World Health Organization (WHO)-recommended range, with 67.7% having UIC ≥100 µg/L. However, 22.8% had a UIC of 50–100 µg/L and 9.5% <50 µg/L. In pregnant women, the median UIC was 128 µg/L (IQR: 84–187), below the WHO threshold of 150 µg/L, with 61.2% having UIC <150 µg/L and 34.4% <100 µg/L. 73.7% of pregnant women used iodide + folic acid supplement, with wide provincial variation of 38–84%. Household salt median iodine content was 32 ppm, but 30.6% of samples were <20 ppm, and only 54% were stored properly. Production-level salt had a median iodine content of 33.8 ppm. Conclusions: Although Iran has maintained iodine sufficiency in the general population during the last three decades, mild iodine deficiency has reappeared among pregnant women due to incomplete usage of iodide folic acid supplementation. Strengthened monitoring, stricter quality assurance in salt production, improved adherence to iodine supplementation in pregnant women, and targeted provincial interventions are needed to sustain IDD elimination.

10 August 2026 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
AAAtieh Amouzegar
Atieh Amouzegar
SASadaf Agahi
Sadaf Agahi
SMSafdar Masoumi
Safdar Masoumi
MTMohamadamin Tarighat-Payma
Mohamadamin Tarighat-Payma
MHMohammadjavad Honarvar
Mohammadjavad Honarvar
LMLadan Mehran
Ladan Mehran